This socalled citizens petition asked the fda not to approve the generic epi pen reportedly designed by israeli pharma company. In a study paid for by mylan, the Generic Product would have a failure rate of 93 . But the study had no control group. And participants did not actually manipulate the device or perform the injection. The study was just flawed from start to finish. Reporter Diana Zuckerman heads a nonprofit fda watchdog. She said studies like this waste health regulatorregulators tim stall approval of Generic Products. Michael carrier has studied more than a decades worth of citizens petitions and found nine out of ten come not from patients, but from brand Name Companies arguing that cheaper generics should be blocked. Its not about what a citizen petition is about, its really about the brand company, delaying the generic form from entering the market. Its being used by industry, it should be called an industry competitors petition. We hope the fda would know better than to
Ive got goretex pants, long johns and everything i own on i think. Beside just making a lot of us miserable, this record setting cold has cracked rail lines, broken water mains and its set some of to us arguing about how long its been since its been this freezing. This mornings record low 5 degrees at Reagan National airport breaks the old record of 8 degrees set back when Grover Cleveland was president. Show me the money. Reporter Terry Mcguire was in theaters in 1996 the last time we hit 5 degrees. People have got to know whether or not their president is a crook. Well, im not a crook. Reporter and Richard Nixon was still in the white house the last time we broke a record low temperature in february. Rails cracked by the cold left people jammed on the platform at falls church. A water leak at lenfant shut down the power and may have contributed to the crush of passengers at judiciary square. A water main blocked traffic at new york avenue and north capitol and in cabin john fireplace
The FDA said nothing about the payments from the North Chicago company when the panel met to assess new technology, a "breakthrough device" for which the agency "may be willing to accept greater uncertainty" when considering risks and benefits.